Influenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Influenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen
Accession Number
DB14447
Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Attenuated
Description

Influenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen is a vaccine.

Synonyms
  • Influenza a Virus A/uruguay/716/2007(h3n2) Live(attenuated) Antigen
  • Influenza a Virus H3n2 Live Antigen, A
Active Moieties
NameKindUNIICASInChI Key
Influenza A virusunknownR9HH0NDE2ENot AvailableNot applicable
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
FluMistInfluenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen (10000000 1/0.2mL) + Influenza a virus a/south dakota/6/2007 (h1n1) live (attenuated) antigen (10000000 1/0.2mL) + Influenza b virus b/brisbane/60/2008 live (attenuated) antigen (10000000 1/0.2mL)SprayNasalMed Immune, Llc2009-07-172010-04-19Us
Categories
Not Available
UNII
55QXD8HC6H
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailableFlu caused by Influenza / Healthy Volunteers1
1CompletedNot AvailableMalignancies1
1CompletedBasic ScienceHealthy Volunteers1
1CompletedBasic ScienceInfluenza, Human1
1CompletedPreventionFlu caused by Influenza1
1CompletedPreventionHealthy Volunteers1
1CompletedPreventionMalignancies1
1, 2CompletedPreventionEgg Allergy / Eligible for Vaccination Against Influenza1
1, 2CompletedPreventionFlu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections1
1, 2TerminatedPreventionInfluenza, Human1
2CompletedPreventionFlu caused by Influenza1
2CompletedPreventionHealthy Volunteers1
2CompletedTreatmentHealthy Volunteers2
2CompletedTreatmentInfluenza Vaccines1
2, 3CompletedPreventionHealthy or Stable Underlying Chronic Medical Condition1
3CompletedNot AvailableFlu caused by Influenza / Healthy Volunteers1
3CompletedPreventionFlu caused by Influenza3
3CompletedPreventionHealthy or Stable Chronic Illness1
3CompletedPreventionHealthy or Stable Underlying Chronic Medical Condition1
3CompletedTreatmentHealthy Volunteers2
4CompletedNot AvailableFlu caused by Influenza1
4CompletedNot AvailableHealthy Volunteers1
4CompletedBasic ScienceFlu caused by Influenza8
4CompletedBasic ScienceFlu caused by Influenza / Healthy Volunteers2
4CompletedBasic ScienceImmune Response to Influenza Vaccine / Influenza A Virus Infection / Influenza B Virus Infection1
4CompletedHealth Services ResearchInfluenza, Human / Pneumonia1
4CompletedPreventionAsthma Bronchial1
4CompletedPreventionFlu caused by Influenza7
4CompletedPreventionFlu caused by Influenza / Healthy Volunteers1
4CompletedPreventionInfluenza Vaccines Efficacy and Safety1
4CompletedPreventionInfluenza Virus Infection / Influenza-like Illness / Respiratory Infections, Acute1
4CompletedTreatmentFlu caused by Influenza2
4CompletedTreatmentHealthy Volunteers1
4Not Yet RecruitingBasic ScienceFlu caused by Influenza2
4RecruitingPreventionImmune Response / Influenza, Human1
4TerminatedBasic ScienceFlu caused by Influenza2
4TerminatedPreventionFlu caused by Influenza1
4Unknown StatusBasic ScienceFlu caused by Influenza1
Not AvailableCompletedNot AvailableCentral Nervous System Neoplasms1
Not AvailableCompletedNot AvailableEgg Hypersensitivity1
Not AvailableCompletedNot AvailableFlu caused by Influenza / H1N1 / Human Immunodeficiency Virus Type 1 (HIV-1) Infection1
Not AvailableCompletedNot AvailableHealthy Volunteers2
Not AvailableCompletedBasic ScienceFlu caused by Influenza1
Not AvailableCompletedHealth Services ResearchImmune Response to Influenza Vaccination1
Not AvailableCompletedTreatmentFlu caused by Influenza1
Not AvailableEnrolling by InvitationPreventionTonsillitis, Hypertrophy1
Not AvailableRecruitingNot AvailableHabits / Influenza, Human / Respiratory Tract Infections (RTI) / Smoking1
Not AvailableRecruitingBasic ScienceHealthy Volunteers1
Not AvailableTerminatedBasic ScienceFlu caused by Influenza1
Not AvailableUnknown StatusNot AvailableCystic Fibrosis (CF)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
SprayNasal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on July 05, 2018 12:03 / Updated on September 02, 2019 20:17